Azitra (AZTR) Current Taxes (2024 - 2025)
Azitra's (AZTR) quarterly Current Taxes came in at $6256.0 in Q4 2025, down 45.94% YoY from $11572.0 in Q4 2024, and down 45.94% on a QoQ basis from $11572.0 in Q4 2024.
Azitra (AZTR) Current Taxes (2024 - 2025) Analysis & Trends
Azitra (AZTR) has 2 years of Current Taxes data on file, last reported at $6256.0 in Q4 2025.
- Quarterly Current Taxes fell 45.94% year-over-year to $6256.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6256.0 (down 45.94% YoY) and the FY2025 annual result came in at $6256.0, down 45.94% from the prior year.
- Current Taxes declined to $6256.0 in Q4 2025, from $11572.0 in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $11572.0 in Q4 2024 to a low of $6256.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.01 Bn | 132.16 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.79 Bn | 78.79 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn | 49.00 Mn |
| 4 | Moderna | 60.18 Bn | 55.04 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 76.32 Mn |
| 6 | Alnylam Pharmaceuticals | 31.55 Bn | 28.24 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.45 Bn | 10.06 Bn | 668.28 Mn | 76.36 Mn |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.19 Bn | 26.36 Bn | - | - |
| 10 | Azitra | 2.61 Mn | 2.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6,256.00 |
| Dec 31, 2024 | 11,572.00 |